OpenSky Ventures — 2023 Investments
3 investments dated 2023 · listed companies and verified rows first · show all
Avilar develops ATACs (ASGPR Targeting Chimeras), a class of protein degraders designed to target extracellular and membrane-bound proteins by harnessing the endolysosome's natural degradation process.
BiotechWaltham, US
THERESA CAMERON(Director)MARTIN FREED(Director)STEPHANIE TOZZO(Executive Officer)PHIL GRAHAM(Executive Officer)MILIND DESHPANDE(Director)DAVID NEAFUS(Executive Officer)
Board seatJoshua Resnick· per SEC Form D · $75.3M raise · filed Feb 2023
Co-investorsAstellas Venture Management LLCMedical Excellence CapitalRA CapitalSanofi Ventures
Daash Intelligence runs an AI-based predictive commerce intelligence platform for beauty and personal care retail brands.
San Francisco, US
Philip Smolin(Executive Officer, Director)Kim Perell(Executive Officer, Director)
BoardRoss Kimbel(Director)
Co-investorsBullpen CapitalGFT VenturesNew Stack VenturesRed Bike CapitalSilicon Road VenturesWillow Growth Partners
Siena is an AI customer experience platform for consumer and ecommerce brands, providing AI agents that handle support, shopping recommendations, social media engagement, post-purchase workflows, and subscription management across customer channels.
AI & Machine LearningE-commerceSaaS
Lisa Popovici(Founder)in
Co-investorsAglae VenturesSierra VenturesSuperAngel.FundThe CouncilVillage Global
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.